Genetics of SLE: Evidence from mouse models

Nature Reviews Rheumatology

Volumn 6, Issue 6, 2010, Pages 348-357

  Morel, Laurence ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; AUTOPHAGY PROTEIN 5; B CELL ACTIVATING FACTOR; B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4A; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FC RECEPTOR IIB; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 10; INTERLEUKIN 4; KALLIKREIN; KHELLIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN KINASE LYN; SECURIN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; STAT4 PROTEIN;

ALLELE; AUTOIMMUNITY; DISEASE MODEL; DISEASE PREDISPOSITION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MEDICAL RESEARCH; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SPECIES DIFFERENCE; STRAIN DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, MUTANT STRAINS;

EID: 77953552267     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.63     Document Type: Review

References (108)

1. Theofilopoulos, A. N. & Dixon, F. J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37, 269-379 (1985).
2. Abiola, O. et al. The nature and identification of quantitative trait loci: a community's view. Nat. Rev. Genet. 4, 911-916 (2003).
3. Kono, D. H. & Theofilopoulos, A. N. Genetics of SLE in mice. Springer Semin. Immunopathol. 28, 83-96 (2006).
4. Wakeland, E. K., Liu, K., Graham, R. R. & Behrens, T. W. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15, 397-408 (2001).
5. The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN) et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet. 40, 204-210 (2008).
6. Horn, G. et al. Association of systemic lupus erythematosus with C8orf1-BLK and ITGAM-ITGAX. N. Engl. J. Med. 358, 900-909 (2008).
7. Graham, R. R. et al. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40, 1059-1061 (2008).
8. Kozyrev, S. V. et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40, 211-216 (2008).
9. Harley, I. T., Kaufman, K. M., Langefeld, C. D., Harley, J. B. & Kelly, J. A. Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studies. Nat. Rev. Genet. 10, 285-290 (2009).
10. Mohan, C., Alas, E., Morel, L., Yang, P. & Wakeland, E. K. Genetic dissection of SLE pathogenesis: Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J. Clin. Invest. 101, 1362-1372 (1998).
11. Waters, S.T. et al. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J. Exp. Med. 199, 255-264 (2004).
12. Morel, L. et al. Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl Acad. Sci. USA 97, 6670-6675 (2000).
13. Morel, L., Blenman, K. R., Croker, B. P. & Wakeland, E. K. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc. Natl Acad. Sci. USA 98, 1787-1792 (2001).
14. Chen, Y., Cuda, C. & Morel, L. Genetic determination of T cell help in loss of tolerance to nuclear antigens. J. Immunol. 174, 7692-7702 (2005).
15. Cuda, C. M., Zeumer, L., Sobel, E. S., Croker, B.P. & Morel, L. Murine lupus susceptibility locus Sle1a requires the expression of two subloci to induce inflammatory T cells. Genes Immun. (in press).
16. Rahman, Z. S. M. et al. Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production. Genes Immun. 8, 604-612 (2007).
17. Wandstrat, A. E. et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 21, 769-780 (2004).
18. Kumar, K. R. et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 312, 1665-1669 (2006).
19. Boackle, S. A. et al. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15, 775-785 (2001).
20. Chen, Y. et al. Several genes contribute to the production of autoreactive B and T cells in the murine lupus susceptibility locus Sle1c. J. Immunol. 175, 1080-1089 (2005).
21. Cuda, C.M., Wan, S., Sobel, E. S., Croker, B.P. & Morel, L. Murine lupus susceptibility locus Sle1a controls regulatory T cell number and function through multiple mechanisms. J. Immunol. 179, 7439-7447 (2007).
22. Peters, L. L. et al. The mouse as a model for human biology: a resource guide for complex trait analysis. Nat Rev. Genet 8, 58-69 (2007).
23. Chen, Y., Rollins, J., Paigen, B. & Wang, X. Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab. 6, 164-179 (2007).
24. Mouse Phenome Database. Mouse SNPs [online], http://www.iax.org/phenome/ SNP (2010).
25. Xiu, Y. et al. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J. Immunol. 169, 4340-4346 (2002).
26. Lee, Y. H., Ji, J. D. & Song, G. G. Fcγ receptor IIB and IIIB polymorphisms and susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Lupus 18, 727-734 (2009).
27. Mackay, M. et al. Selective dysregulation of the Fcγ11B receptor on memory B cells in SLE. J. Exp. Med. 203, 2157-2164 (2006).
28. Wu, H. et al. Association of a common complement receptor 2 haplotype with increased risk of systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 104, 3961-3966 (2007).
29. Douglas, K. B. et al. Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing. Genes Immun. 10, 457-469 (2009).
30. Schwartzberg, P. L., Mueller, K. L., Qi, H. & Cannons, J. L. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat. Rev. Immunol. 9, 39-46 (2009).
31. Graham, D. S. C. et al. Association of LY9 in UK and Canadian SLE families. Genes Immun. 9, 93-102 (2008).
32. Suzuki, A. et al. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. Nat Genet. 40, 1224-1229 (2008).
33. Zhu, J. K. et al. T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J. Clin. Invest. 115, 1869-1878 (2005).
34. Mohan, C., Yu, Y., Morel, L., Yang, P. & Wakeland, E. K. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J. Immunol. 162, 6492-6502 (1999).
35. Liu, K. et al. Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J. Clin. Invest. 119, 911-923 (2009).
36. Rogers, N. J. et al. A defect in Marco expression contributes to systemic lupus erythematosus development via failure to clear apoptotic cells. J. Immunol. 182, 1982-1990 (2009).
37. Haraldsson, M. K. et al. The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. Immunity 28, 40-51 (2008).
38. Limaye, N. et al. Prevalence and evolutionary origins of autoimmune susceptibility alleles in natural mouse populations. Genes Immun. 9, 61-68 (2007).
39. Mehrad, B. et al. The lupus-susceptibility locus, Sle3, mediates enhanced resistance to bacterial infections. J. Immunol. 176, 3233-3239 (2006).
40. Cohen, P.L. & Eisenberg, R. A. The Ipr and gld genes in systemic autoimmunity: life and death in the Fas lane. Immunol. Today 13, 427-428 (1992).
41. Pisitkun, P. et al. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312, 1669-1672 (2006).
42. Subramanian, S. et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl Acad. Sci. USA 103, 9970-9975 (2006).
43. Tivol, E. A. et al. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
44. + anti-DNA plasma cells. Nat. Immunol. 6, 99-106 (2005).
45. Bygrave, A. E. et al. Spontaneous autoimmunity in 129 and C57BL/6 mice - implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2, 1081-1090 (2004).
46. Vinuesa, C. G. & Goodnow, C. C. Illuminating autoimmune regulators through controlled variation of the mouse genome sequence. Immunity 20, 669-679 (2004).
47. Gateva, V. et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet 41, 1228-1233 (2009).
48. Wu, M. C., Huang, C. M., Tsai, J. J., Chen, H. Y. & Tsai, F. J. Polymorphisms of the interleukin-4 gene in Chinese patients with systemic lupus erythematosus in Taiwan. Lupus 12, 21-25 (2003).
49. Kim, K. et al. A regulatory SNP at position -899 in CDKN1A is associated with systemic lupus erythematosus and lupus nephritis. Genes Immun. 10, 482-486 (2009).
50. Graham, R. R., Horn, G., Ortmann, W. & Behrens, T. W. Review of recent genome-wide association scans in lupus. J. Intern. Med. 265, 680-688 (2009).
51. Cheema, G. S., Roschke, V., Hilbert, D. M. & Stohl, W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 44, 1313-1319 (2001).
52. Doreau, A. et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10, 778-785 (2009).
53. Chaussabel, D. et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150-164 (2008).
54. b converts two pure nonlupus mouse strains to producers of antinuclear antibodies. J. Immunol. 183, 3542-3550 (2009).
55. Jacob, C. O. et al. Heritable major histocompatibility complex class-II-associated differences in production of tumor necrosis factor-alpha: relevance to genetic predisposition to systemic lupus-erythematosus. Proc. Natl Acad. Sci. USA 87, 1233-1237 (1990).
56. Zhang, D. Q. et al. Dissection of the role of MHC class IIA and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination. Proc. Natl Acad. Sci. USA 101, 13838-13843 (2004).
57. Jacob, C. O. et al. Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J. Immunol. 171, 1564-1571 (2003).
58. Xu, Z., Duan, B., Croker, B. P. & Morel, L. STAT4 deficiency reduces autoantibody production and glomerulonephritis in a mouse model of lupus. Clin. Immunol. 120, 189-198 (2006).
59. Korman, B. D., Kastner, D. L., Gregersen, P K. & Remmers, E. F STAT4: genetics, mechanisms, and implications for autoimmunity. Curr. Allergy Asthma Rep. 8, 398-403 (2008).
60. Zikherman, J. et al. PTPN22 deficiency cooperates with the CD45 E613R allele to break tolerance on a non-autoimmune background. J. Immunol. 182, 4093-4106 (2009).
61. Vang, T. et al. Protein tyrosine phosphatases in autoimmunity. Ann. Rev. Immunol. 26, 29-55 (2008).
62. Jacob, C. O. et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc. Natl Acad. Sci. USA 106, 6256-6261 (2009).
63. Gottipati, S., Rao, N. L. & Fung-Leung, W.P. IRAKI: a critical signaling mediator of innate immunity. Cell. Signal. 20, 269-276 (2008).
64. Yin, Z. N. et al. IL-10 regulates murine lupus. J. Immunol. 169, 2148-2155 (2002).
65. Moore, K. W., de Waal Malefyt, R., Coffman, R. L. & O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 19, 683-765 (2003).
66. Ipr mice from autoimmune disease. Am. J. Pathol. 165, 609-616 (2004).
67. Bullard, D. C. et al. Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J. Immunol. 175, 6327-6333 (2005).
68. Oliva, C.R. et al. The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes. Proc. Natl Acad. Sci. USA 105, 1261-1266 (2008).
69. Paun, A. et al. Functional characterization of murine interferon regulatory factor 5 (IRF-5) and its role in the innate antiviral response. J. Biol. Chem. 283, 14295-14308 (2008).
70. Yasuda, K. et al. Murine dendritic cell type IIFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J. Immunol. 178, 6876-6885 (2007).
71. Saijo, K. et al. Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development. Nat. Immunol. 4, 274-279 (2003).
72. Tong, Y., Tan, Y., Zhou, C. & Melmed, S. Pituitary tumor transforming gene interacts with Sp1 to modulate G1//S cell phase transition. Oncogene 26, 5596-5605 (2007).
73. Munz, C. Enhancing immunity through autophagy. Ann. Rev. Immunol. 27, 423-449 (2009).
74. Croft, M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev. Immunol. 9, 271-285 (2009).
75. Vereecke, L., Beyaert, R. & van Loo, G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 30, 383-391 (2009).
76. Verstrepen, L., Carpentier, I., Verhelst, K. & Beyaert, R. ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling. Biochem. Pharmacol. 78, 105-114 (2009).
77. Aiba, Y. et al. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity 24, 259-268 (2006).
78. Martins, G. & Calame, K. Regulation and functions of Blimp-1 in T and B lymphocytes. Ann. Rev. Immunol. 26, 133-169 (2008).
79. Nimmerjahn, F. & Ravetch, J. V. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34-47 (2008).
80. Moser, K. L., Kelly, J. A., Lessard, C. J. & Harley, J. B. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 10, 373-379 (2009).
81. Kontoyiannis, D. & Kollias, G. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur. J. Immunol. 30, 2038-2047 (2000).
82. Paisansinsup, T., Vallejo, A. N., Luthra, H. & David, C. S. HLA-DR modulates autoantibody repertoire, but not mortality, in a humanized mouse model of systemic lupus erythematosus. J. Immunol. 167, 4083-4090 (2001).
83. Manz, M. G. & Di Santo, J. P. Renaissance for mouse models of human hematopoiesis and immunobiology. Nat. Immunol. 10, 1039-1042 (2009).
84. Yu, D. et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 450, 299-303 (2007).
85. Vinuesa, C. G., Rigby, R. J. & Yu, D. Logic and extent of miRNA-mediated control of autoimmune gene expression. Int. Rev. Immunol. 28, 112-138 (2009).
86. Liu, K. et al. Sle3 and Sle5 can independently couple with Slel to mediate severe lupus nephritis. Genes Immun. 8, 634-645 (2007).
87. Kong, PL., Morel, L., Croker, B. P. & Craft, J. The centromeric region of chromosome 7 from MRL mice (Lmb3) is an epistatic modifier of Fas for autoimmune disease expression. J. Immunol. 172, 2785-2794 (2004).
88. Subramanian, S. et al. Epistatic suppression of systemic lupus erythematosus: fine mapping of Sles1 to less than 1 Mb. J. Immunol. 175, 1062-1072 (2005).
89. Haywood, M. E. K. et al. Dissection of BXSB lupus phenotype using mice congenic for chromosome 1 demonstrates that separate intervals direct different aspects of disease. J. Immunol. 173, 4277-4285 (2004).
90. Wither, J. E. et al. Functional dissection of lupus susceptibility loci on the New Zealand Black mouse chromosome 1: evidence for independent genetic loci affecting T and B cell activation. J. Immunol. 171, 1697-1706 (2003).
91. Carlucci, F. et al. Genetic dissection of spontaneous autoimmunity driven by 129-derived chromosome 1 loci when expressed on C57BL/6 mice. J. Immunol. 178, 2352-2360 (2007).
92. Rozzo, S. J. et al. Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15, 435-443 (2001).
93. Santiago-Raber, M. L. et al. Fcγ receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice. Arthritis Rheum. 60, 2408-2417 (2009).
94. Ichii, O. et al. Autoimmune glomerulonephritis induced in congenic mouse strain carrying telomeric region of chromosome 1 derived from MRL/MpJ. Histol. Histopathol. 23, 411-422 (2008).
95. Heidari, Y. et al. A lupus-susceptibility C57BL/6 locus on chromosome 3 (Sle18) contributes to autoantibody production in 129 mice. Genes Immun. 10, 47-55 (2008).
96. Liu, Y. et al. Lupus susceptibility genes may breach tolerance to DNA by impairing receptor editing of nuclear antigen-reactive B cells. J. Immunol. 179, 1340-1352 (2007).
97. Mohan, C., Morel, L., Yang, P. & Wakeland, E. K. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J. Immunol. 159, 454-465 (1997).
98. Xu, Z., Duan, B., Croker, B. P., Wakeland, E. K. & Morel, L. Genetic dissection of the murine lupus susceptibility locus Sle2: contributions to increased peritoneal B-1a cells and lupus nephritis map to different loci. J. Immunol. 175, 936-943 (2005).
99. Li, J. et al. Deficiency of type I interferon contributes to Sle2-associated component lupus phenotypes. Arthritis Rheum. 52, 3063-3072 (2005).
100. Loh, C. et al. Dissociation of the genetic loci leading to B1a and NKT cell expansions from autoantibody production and renal disease in B6 mice with an introgressed New Zealand Black chromosome 4 interval. J. Immunol. 178, 1608-1617 (2007).
101. Haraldsson, M. K. et al. Autoimmune alterations induced by the New Zealand Black Lbw2 locus in BWF1 mice. J. Immunol. 174, 5065-5073 (2005).
102. Kikuchi, S. et al. Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis. J. Immunol. 174, 1111-1117 (2005).
103. Ipr congenic mice reveals significant effects from Lmb3. J. Immunol. 178, 8195-8202 (2007).
104. 2autoantibodies without altering intrinsic B cell-tolerance mechanisms. J. Immunol. 180, 3807-3814 (2008).
105. Laporte, C., Ballester, B., Mary, C., Izui, S. & Reininger, L. The Sgp3 locus on mouse chromosome 13 regulates nephritogenic gp70 autoantigen expression and predisposes to autoimmunity. J. Immunol. 171, 3872-3877 (2003).
106. Yoshinobu, K. et al. Selective up-regulation of intact, but not defective env RNAs of endogenous modified polytropic retrovirus by the Sgp3 locus of lupus-prone mice. J. Immunol. 182, 8094-8103 (2009).
107. Wither, J. E. et al. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand Black chromosome 13 interval. J. Immunol. 175, 4309-4319 (2005).
108. Cook, M. C., Vinuesa, C. G. & Goodnow, C. C. ENU-mutagenesis: insight into immune function and pathology. Curr. Opin. Immunol. 18, 627-633 (2006).